Extramedullary Plasmacytoma, also known as extraosseous plasmacytoma, is related to plasmacytoma and heavy chain disease. An important gene associated with Extramedullary Plasmacytoma is MYOM2 (Myomesin 2), and among its related pathways/superpathways are Innate Immune System and NF-kappaB Signaling. The drugs Bortezomib and Cyclophosphamide have been mentioned in the context of this disorder. Affiliated tissues include liver and lymph node, and related phenotypes are Reduced mammosphere formation and cellular